Review highlights continuous glucose monitoring characteristics in MODY subtypes, suggesting implications for clinical management.
BACKGROUND: Maturity-onset diabetes of the young (MODY) is a heterogeneous monogenic diabetes category caused by defects in genes involved in pancreatic β-cell development, glucose sensing, or insulin secretion. In children, adolescents, and young adults, its clinical presentation may overlap with type 1 diabetes (T1D) or early-onset type 2 diabetes (T2D), which can complicate etiological classification. CONTENT: -, and KATP channel-related MODY. PubMed/MEDLINE, Embase, Web of Science Core Collection, and Scopus were searched through March 1, 2026, with supplementary citation tracking. Priority was given to genetically confirmed or clearly defined studies reporting CGM/flash glucose monitoring (FGM) metrics, glycemic variability, hypoglycemic exposure, or treatment-transition data. SUMMARY AND OUTLOOK: ) by showing stable mild hyperglycemia, postprandial excursions, nocturnal or asymptomatic hypoglycemia, and treatment-related fluctuations. It should not be used as a substitute for genetic diagnosis. Multicenter, genetically confirmed studies using standardized CGM metrics are needed to clarify its role in precision management.
No takes yet. Share an insight, caveat, or question.
Rouzimaimaiti et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: